A little over a year after completing a pilot study, pharmaceutical company AstraZeneca and Exco InTouch have launched a mobile-enabled program in the UK to help patients manage their chronic obstructive pulmonary disease (COPD), called Me&MyCOPD.
The program has three components -- a portal in which patients can connect with providers, a server on which information is saved and messages are...
